COMPOSITIONS AND METHODS FOR MODULATING GHRELIN-MEDIATED CONDITIONS
    1.
    发明申请
    COMPOSITIONS AND METHODS FOR MODULATING GHRELIN-MEDIATED CONDITIONS 有权
    用于调节GHRELIN介质条件的组合物和方法

    公开(公告)号:US20100196396A1

    公开(公告)日:2010-08-05

    申请号:US12700009

    申请日:2010-02-04

    摘要: In certain aspects, the preproghrelin gene, but not the ghrelin receptor (GHS-R1a) is required for normal integration of thermoregulation and sleep in mice. Particular aspects provide methods for modulation of thermoregulation and other ghrelin-mediated conditions (e.g., reduction of appetite or food intake, reduction of body weight or treatment of obesity, reduction of body temperature or induction of hypothermia, etc.), comprising administration of an inhibitor of ghrelin expression, and including, e.g., siRNA inhibition for treatment of obesity and for modulation of thermoregulation (e.g., induction of hypothermia in surgical settings benefiting from same). Additionally provided are methods for reducing body temperature or induction of hypothermia, comprising administration to a mammalian subject in need thereof an amount of an anti-obestatin antibody agent sufficient to reduce body temperature or induce hypothermia. Further methods comprise administration of a ghrelin peptide antagonist.

    摘要翻译: 在某些方面,在小鼠体内正常的体温调节和睡眠整合需要预干扰素基因而不是生长素释放肽受体(GHS-R1a)。 特定方面提供调节温度调节和其他生长素释放肽介导的条件(例如减少食欲或食物摄入,减轻体重或治疗肥胖,降低体温或诱导低体温等)的方法,包括施用 并且包括例如用于治疗肥胖症和用于调节体温调节的siRNA抑制(例如,从受益于其的手术设置中诱导低体温)的抑制剂。 另外提供了用于降低体温或诱导低体温的方法,包括向有需要的哺乳动物受试者施用足量降低体温或诱发低体温的抗肥胖抑制素抗体剂量。 其它方法包括施用生长素释放肽肽拮抗剂。

    Compositions and methods for modulating ghrelin-mediated conditions
    3.
    发明授权
    Compositions and methods for modulating ghrelin-mediated conditions 有权
    用于调节生长素释放肽介导的病症的组合物和方法

    公开(公告)号:US08309530B2

    公开(公告)日:2012-11-13

    申请号:US12700009

    申请日:2010-02-04

    IPC分类号: C12N15/11

    摘要: In certain aspects, the preproghrelin gene, but not the ghrelin receptor (GHS-R1a) is required for normal integration of thermoregulation and sleep in mice. Particular aspects provide methods for modulation of thermoregulation and other ghrelin-mediated conditions (e.g., reduction of appetite or food intake, reduction of body weight or treatment of obesity, reduction of body temperature or induction of hypothermia, etc.), comprising administration of an inhibitor of ghrelin expression, and including, e.g., siRNA inhibition for treatment of obesity and for modulation of thermoregulation (e.g., induction of hypothermia in surgical settings benefiting from same). Additionally provided are methods for reducing body temperature or induction of hypothermia, comprising administration to a mammalian subject in need thereof an amount of an anti-obestatin antibody agent sufficient to reduce body temperature or induce hypothermia. Further methods comprise administration of a ghrelin peptide antagonist.

    摘要翻译: 在某些方面,在小鼠体内正常的体温调节和睡眠整合需要预干扰素基因而不是生长素释放肽受体(GHS-R1a)。 特定方面提供调节温度调节和其他生长素释放肽介导的条件(例如减少食欲或食物摄入,减轻体重或治疗肥胖,降低体温或诱导低体温等)的方法,包括施用 并且包括例如用于治疗肥胖症和用于调节体温调节的siRNA抑制(例如,从受益于其的手术设置中诱导低体温)的抑制剂。 另外提供了用于降低体温或诱导低体温的方法,包括向有需要的哺乳动物受试者施用足量降低体温或诱发低体温的抗肥胖抑制素抗体剂量。 其它方法包括施用生长素释放肽肽拮抗剂。

    Administering bacteria to improve sleep
    6.
    发明授权
    Administering bacteria to improve sleep 失效
    管理细菌以改善睡眠

    公开(公告)号:US06444203B2

    公开(公告)日:2002-09-03

    申请号:US09466768

    申请日:1999-12-20

    IPC分类号: A01N6302

    摘要: A method of improving sleep in a mammal having a sleep disorder is disclosed. The method includes identifying the mammal having a sleep disorder and then administering Lactobacillus acidophilus CNCM I-2274, Lactobacillus acidophilus CNCM I-2132, Lactobacillus helveticus CNCM I-2275, Streptococcus thermophilus CNCM I-1520, Streptococcus thermophilus CNCM I-2272 or mixtures thereof. The method increases the length of the non rapid eye movement sleep phase and decreases the length of the rapid eye movement sleep phase. The bacteria can be administered in an orally consumable food product or a dietary supplement.

    摘要翻译: 公开了一种改善睡眠障碍的哺乳动物睡眠的方法。 该方法包括鉴定具有睡眠障碍的哺乳动物,然后施用嗜酸乳杆菌CNCM I-2274,嗜酸乳杆菌CNCM I-2132,瑞士乳杆菌CNCM I-2275,嗜热链球菌CNCM I-1520,嗜热链球菌CNCM I-2272或其混合物 。 该方法增加了非快速眼动睡眠期的长度,并减少了快速眼动睡眠期的长度。 细菌可以在口服食品或膳食补充剂中施用。